Stephane Potteaux

Has grant

Université de Reims Champagne-Ardenne

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Link between cancer and atherosclerosis

Open Date:

Close Date:

Grant: Close

Role of hypercholesterolemia in cancer development

Open Date:

Close Date:

Grant: Close

Isoformes de l’IL-17 : de nouvelles cibles thérapeutiques dans le cancer du sein triple négatif

Open Date:

Close Date: 2021-01-01

Grant: Close

Isoformes de l'IL-17: de nouvelles cibles thérapeutiques dans le cancer du sein triple négatif

Open Date:

Close Date: 2021-01-01

Grant: Close

Early diagnosis of triple negative breast cancers and prediction of radiotherapy resistance by Fourier-Transform-infrared spectral imaging

Open Date:

Close Date:

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (6)

Ludivine Laurans

INSERM

FRANCE

View details

Corinne Tanchot

Université Paris Cité

FRANCE

View details

Ziad Mallat

University of Cambridge

UNITED KINGDOM

View details

Hafid Ait-Oufella

Université Paris-Saclay

FRANCE

View details

Olivia Lenoir

Researcher-Associate professor

INSERM

FRANCE

View details

Emmanuel Pinteaux

The University of Manchester

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Stephane Potteaux

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Ustekinumab as a potential therapeutic agent in Bullous Pemphigoid: a biological and clinical proof-of-concept study

Enhanced expression of galectin‐9 in triple negative breast cancer cells following radiotherapy: Implications for targeted therapy

Elastin-derived peptides favor type 2 innate lymphoid cells in chronic obstructive pulmonary disease

Identification of CD160-TM as a tumor target on triple negative breast cancers: possible therapeutic applications

Une dyslipidémie modérée accélère la croissance tumorale par l’accumulation de cellules myéloïdes immunosuppressives et pro-angiogéniques

Mild dyslipidemia accelerates tumor growth through expansion of immunosuppressive and pro-angiogenic myeloid cells

Mild dyslipidemia accelerates tumorigenesis through expansion of Ly6C<sup>hi</sup> monocytes and differentiation to pro-angiogenic myeloid cells.

Mild dyslipidemia accelerates tumorigenesis through expansion of Ly6C(hi) monocytes and differentiation to pro-angiogenic myeloid cells

Myocardial infarction exacerbates protumoral and immunosuppressive functions of inflammatory monocytes: A link between cardiovascular diseases and cancer

Thymic stromal lymphopoietin is a key cytokine for the immunomodulation of atherogenesis with Freund's adjuvant

Collaborators (6)

Ludivine Laurans

Corinne Tanchot

Ziad Mallat

Hafid Ait-Oufella

Olivia Lenoir

Emmanuel Pinteaux

Make your next move.